Short-term variability of Alzheimer’s disease plasma biomarkers in a mixed memory clinic cohort
Abstract Background For clinical implementation of Alzheimer’s disease (AD) blood-based biomarkers (BBMs), knowledge of short-term variability, is crucial to ensure safe and correct biomarker interpretation, i.e., to capture changes or treatment effects that lie beyond that of expected short-term va...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
BMC
2025-01-01
|
| Sraith: | Alzheimer’s Research & Therapy |
| Ábhair: | |
| Rochtain ar líne: | https://doi.org/10.1186/s13195-024-01658-7 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
